REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

Similar documents
WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Smokefree Policies in Europe: Are we there yet?

Outcome of proficiency test on EIA serology

Where we stand in EFORT

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Monthly measles and rubella monitoring report

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Cross Border Genetic Testing for Rare Diseases

Overview of drug-induced deaths in Europe - What does the data tell us?

European status report on alcohol and health Leadership, awareness and commitment

Alcohol-related harm in Europe and the WHO policy response

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Q1 What age are you?

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Engagement in language assessment / Regions of Europe

Measles and rubella monitoring January 2015

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

LEBANON. WCPT COUNTRY PROFILE December 2018

The Identification of Food Safety Priorities using the Delphi Technique

European Status report on Alcohol and Health

DENMARK. WCPT COUNTRY PROFILE December 2018

European Community Pharmacy: a reference in Public Health

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

GERMANY. WCPT COUNTRY PROFILE December 2018

The cancer burden in the European Union and the European Region: the current situation and a way forward

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

European Collaboration on Dementia. Luxembourg, 13 December 2006

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Summary. Primary care data. Week 49/2014. Season

EUVAC.NET A surveillance network for vaccine-preventable diseases

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

ROMANIA NATIONAL SANITARY VETERINARY AND FOOD SAFETY AUTHORITY

Transmission, processing and publication of HBS 2015 data

This document is a preview generated by EVS

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

COMMISSION OF THE EUROPEAN COMMUNITIES

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

HPAI H5(N8) in Member States in poultry, captive and wild birds

Overview of European Consumption Databases

Highlighting in the WHO European Region:

Outline of the presentation

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Ministry of Agriculture RABIES CO-FINANCED ERADICATION PROGRAMME IN HUNGARY 2014 SCOPAFF

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Results of the implementation of the Rabies co-financed eradication programme in 2011 ESTONIA

Prevention of Oral Cancer Special Interest Working Group

Lumpy skin disease (LSD) & Sheep Pox. State of play in the EU

Overall survival: 1 st line therapy

Table 7.1 Summary information for lung cancer in Ireland,

Where do EU Contries set the limit for low risk drinking.

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

European Association of Dental Public Health Prevention of Oral Cancer

Table 9.1 Summary information for stomach cancer in Ireland,

Access to treatment and disease burden

REPORT ON THE TASK FORCE MEETING OF THE RABIES SUBGROUP November Zagreb, Croatia

11 Melanoma of the skin

UK bowel cancer care outcomes: A comparison with Europe

Report summary. From 01/01/2014 to 11/05/2014

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Table 6.1 Summary information for colorectal cancer in Ireland,

Rheumatoid Arthritis Disease Burden and Access to Treatment

Real Life, Real PD Survey

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Underage drinking in Europe

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Best practices in collecting and processing data in CRC screening and after it

Standing Group of Experts on LSD in South-East Europe

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Lumpy skin disease (LSD) Epidemiological situation in Europe (update since LSD4)

Republic of Serbia Ministry of Agriculture, Forestry and Water Management Veterinary Directorate. Rabies control and eradication in Serbia

Nutrient profiles for foods bearing claims

Alcohol Prevention Day

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

L 322/24 Official Journal of the European Union

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Greek Rabies Eradication Program

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Transcription:

European Union European Union WHO Collaborating OIE Reference Reference Centre Reference NANCY LABORATORY FOR RABIES AND WILDLIFE Laboratory for Rabies Institute for Rabies Serology for Research and Management Laboratory for Rabies REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015 E. Robardet and F. Cliquet June 2016 French Agency for Food, Environmental and Occupational Health Safety Nancy Laboratory for Rabies and Wildlife Technopole Agricole et Vétérinaire, Domaine de Pixerécourt, Bâtiment H, CS 40009, 54220 Malzéville - France.

TABLE OF CONTENTS 1 GENERAL DATA... 1 2 QUALITY ASSURANCE... 2 3 RABIES DIAGNOSIS IN THE FRAME OF RABIES SURVEILLANCE IN NON FLYING ANIMALS... 3 4 RABIES CASES IN NON FLYING ANIMALS... 6 5 RABIES CASES IN BATS... 7 6 ORAL VACCINATION MONITORING... 8 6.1 ORAL VACCINATION... 8 6.2 SAMPLING PRESSURE IN MONITORING... 10 6.3 PERCENTAGE OF SEROCONVERSION IN THE TARGET POPULATION... 11 6.4 PERCENTAGE OF TETRACYCLINE MARKING PRESENCE IN TARGET POPULATION... 12

An annual activity online questionnaire was submitted to all National Reference Laboratories (NRLs) on last February 2015 to collect and collate data on methods used and results of tests carried out in the Community in the frame of rabies control programmes (Commission regulations (EU) N 737/2008 and N 415/2013). This document reviews the 2015 analysis performed in 27 NRLs from the European Union and in 7 NRLs from third countries involved in a rabies control programme. 1 GENERAL DATA In 2015, the European National Reference Laboratories network for Rabies included 28 laboratories from the European Union. Twenty seven participated in the investigation. To ensure a better overview, some third countries of interest or involved in Oral Rabies Vaccination (ORV) programmes were invited to take part in the study. Seven laboratories (from Kosovo, Former Yugoslav Republic of Macedonia, Montenegro, Serbia, Switzerland, Turkey and Norway) were added in the dataset. At the end, a total of 34 countries were included in the survey (Figure 1), which is the highest number of participants ever recorded. The 2015 survey is consequently the most exhaustive produced review. Figure 1: Map of the participating countries in the 2015 review Review of the analysis related to rabies diagnosis and follow-up of oral vaccination performed in NRLs in 2015 July 2016 Page 1/13

2 QUALITY ASSURANCE In 2015, 27 on 34 laboratories (79%) were accredited according to the ISO EN 17025 system. Each laboratory is accredited for various combinations of techniques. As in previous years, the most widely used techniques under quality assurance system management are the gold standard FAT (65% of laboratories accredited) and the FAVN test (50%) (Figure 2). The proportions did not vary compared to 2014. Fourteen on 34 (41%) participating national laboratories are working in BSL3 facilities. TTC detection Bait titration RFFIT ELISA FAVN Real Time PCR RT-PCR MIT RTCIT FAT 9% 9% 26% 21% 24% 15% 35% 47% 50% 65% 0% 10% 20% 30% 40% 50% 60% 70% Figure 2: Percentage of laboratories accredited for the different techniques related to rabies field (diagnosis techniques in red and monitoring techniques in blue). July 2016 Page 2/13

3 RABIES DIAGNOSIS IN THE FRAME OF RABIES SURVEILLANCE IN NON FLYING ANIMALS As expected, the FAT gold standard technique (OIE, 2013; WHO; 1996) is the mostly used technique (representing 84% of the total amount of diagnosis tests performed during the year and used by 97% of laboratories) (Table 1). The RTCIT is the second most widely used technique (48% of laboratories and 8% of the total amount of diagnosis tests performed during the year) and is often used as confirmatory test (Table 1). Real- Time and RT-PCR techniques are used by 48% and 36% of laboratories respectively. In consequences, proportion of laboratories using Real Time and RTCIT techniques are equivalent. Still 27% of laboratories (n=9) are using the MIT techniques in their rabies diagnosis process although 5 of them are also using the virus isolation on cells (RTCIT) (Table 1). Number of animals analysed in the frame of rabies surveillance programme (bats excluded) varied from 0 to 4958 samples per country (Figure 3). Globally, 139 positive cases were identified for a total of 30 508 FAT (0.005%). Figure 3: Number of FAT performed per country under rabies surveillance programme in non flying species. July 2016 Page 3/13

Table 1: Number of tests performed per country (NRL and regional laboratories data) in 2015 in the frame of rabies diagnosis (non flying animals rabies surveillance only) (Green box: number of test; red box: number of positives cases; i = imported case; v = vaccinal strain; ND= No data) Reference Techniques Molecular Biology Techniques Country FAT RTCIT MIT RT-PCR RealTime Typing n cases Albania 439 12 9 0 0 0 0 Austria 390 64 0 4 3 0 0 Belgium 347 0 0 0 1 0 0 Bulgaria 2497 0 7 0 0 0 0 Croatia 1050 0 0 77 0 0 0 Cyprus 2 0 0 0 0 0 0 Czech Republic 2520 0 186 0 0 0 0 Denmark 3 0 0 0 3 0 0 Estonia 1574 39 0 0 40 0 0 Finland 135 29 0 1 0 0 0 France* 1459 0 0 0 0 0 1 i Germany 4958 224 0 0 2 2 0 Greece 251 0 0 4 85 0 0 Hungary 1110 0 487 0 40 0 1 v Ireland 0 0 0 0 0 0 0 Italy 3496 361 74 302 44 0 0 Kosovo 0 0 0 0 0 0 0 Latvia 206 197 0 10 0 0 0 Lithuania 132 177 0 2 0 2 2 Luxembourg 40 0 0 0 0 0 0 FYROM 241 1 0 0 1 0 0 Montenegro 13 0 0 0 0 0 0 Netherlands 19 0 0 0 0 0 0 Norway 5 0 0 0 13 0 0 Poland 3903 1514 162 177 67 97 93 Portugal 5 5 0 5 0 0 0 Romania 2852 9 129 56 0 56 28 Serbia** 199 3 66 0 0 0 3 Spain 117 0 0 117 117 6 6 i Slovakia 458 0 11 0 201 1 5 Slovenia 1963 89 0 2 2 0 0 Sweden 8 0 0 0 23 0 0 Switzerland 99 89 0 0 0 0 0 United Kingdom 17 2 0 0 2 0 0 Total (n analysis) 30508 2815 1131 757 644 164 140 Total (% analysis) 84% 8% 3% 2% 2% 0.5% Total (n laboratories) 32 16 9 12 16 6 8 Total (% laboratories) 97% 48% 27% 36% 48% 18% 24% * data of RTCIT, MIT, PCR from one of the two laboratories performing diagnosis is missing ** data from one of the two laboratories performing diagnosis is missing July 2016 Page 4/13

Sampling effort in the frame of rabies surveillance has been estimated by dividing the number of FAT tests (excepted bats) by the total area (km 2 ) of the country multiplied by 100. This provided a surveillance indicator of the number of samples analysed for 100 km 2 in each country. As the surveillance system depends upon the epidemiological situation in the country, we divided countries in four groups according to the rabies situation or implementation or not of oral vaccination programme (Table 2). The groups are the following: Group A: Countries with at least one positive case in the year n -1 (2014) and conducting ORV in 2015. Group B: Countries excluded from group A with at least one positive case in a bordering country in the year n -1 (2014) and conducting ORV in 2015. Group C: Countries excluded from group A with at least one positive case in a bordering countries in the year n -1 (2014) and not conducting ORV in 2015. Group D: Countries excluded from groups A, B and C. All are not involved in ORV programmes. As expected, countries without notified rabies case in 2014 nor in their country, nor in their bordering countries, and without ORV programmes present globally a lower surveillance pressure compared to others. Table 2: Number of FAT tests performed in the frame of rabies surveillance programmes (excluding bats) per country for 100 km 2. Countries are classified in groups according to their rabies situation or occurrence of oral vaccination programmes or not. * data from one of the two laboratories performing diagnosis is missing A Bulgaria 2.2 Slovenia 9.7 Czech Republic 3.2 Luxembourg 1.5 Croatia 1.9 Estonia 3.5 C Germany 1.4 Belgium 1.1 Poland 1.2 Albania 1.5 Austria 0.5 Switzerland 0.2 Romania 1.2 Italy 1.2 France 0.2 Hungary 1.2 FYROM 0.9 Netherlands 0.0 B Slovakia 0.9 Latvia 0.3 Spain 0.0 Serbia* 0.2 Lithuania 0.2 D Cyprus 0.0 Greece 0.2 Montenegro 0.1 Denmark 0.0 Finland 0.0 United Kingdom 0.0 Kosovo 0.0 Portugal 0.0 Sweden 0.0 Norway 0.0 Ireland 0.0 July 2016 Page 5/13

4 RABIES CASES IN NON FLYING ANIMALS In 2015, 8 of the 34 (24%) participating laboratories identified a positive case corresponding to a total of 139 detected cases (Figure 4). The highest numbers of rabies cases identified by NRLs and regional laboratories in 2015 were observed in Romania (28) and in Poland (93). Romania recorded a reduced amount of positive cases compared to 2014 and 2013 (462 in 2013, 166 in 2014 and 28 in 2015). Number of detected cases in Hungary decreased from 23 in 2014 to one vaccine induced case in 2015 and not a single rabies case was identified in Greece in 2015 while 10 cases were recorded in 2014. Reoccurrence of rabies (two cases) was reported in Lithuania previously declared free of rabies in early 2015. Rabies imported cases in domestic animals were recorded in both France and Spain as regularly observed in previous years (2014: 5 cases in Spain, 2013: 1 case in France and 5 cases in Spain, 2012: 5 cases in Spain). Four countries finally harboured a low incidence of endemic cases below 5 cases. It should be notified that on French case is not present on the map because detected in French Overseas (One infected dog in French Guinea). Figure 4: Number of reported rabies cases per country in non flying animals in 2015. July 2016 Page 6/13

5 RABIES CASES IN BATS Twenty two countries performed rabies diagnosis on bats routinely (Figure 5). The number of samples tested by FAT throughout 2015 varied from 1 (Slovakia) to 370 (France) tests within the year according to the country. The countries the most implicated in rabies surveillance in bats are principally located in Western Europe (France, United Kingdom, Germany, Netherlands, Poland, Spain and Portugal). Rabies diagnosis technique commonly used to identify a positive case is commonly the FAT even if in some countries molecular biology techniques are principally used instead of reference techniques (Belgium, Italy, Netherlands, Portugal, Sweden). Figure 5: Number of bats tested by FAT per country in 2015 and number of positive cases. July 2016 Page 7/13

6 ORAL VACCINATION MONITORING 6.1 Oral Vaccination Eighteen countries implemented oral vaccination campaigns in 2015 (Table 3 and Figure 6). All countries except Finland, Greece, Italy, Kosovo and FYROM performed two ORV campaigns within the year (one in spring and one in autumn). In 2015, a total of 32 592 749 baits were distributed over 1 635 901 km 2. Bait titration of vaccine batches before release in the field was carried out by all countries excepted one and all the titres of batches were found satisfactory. Figure 6: Oral vaccines used in the oral rabies vaccination and corresponding overall bait density per country. July 2016 Page 8/13

Table 3: Oral vaccination campaigns performed in European countries and number of oral vaccine batches analysed for titration in NRLs Country Number of campaign Bait used Total vaccinated area (km 2 ) (spring + autumn) Total number of baits distributed (spring + autumn) Bait density (baits/km 2 ) N batches analysed Albania 2 Fuschoral 55,798 1,120,000 20 6 Austria No Belgium No Bulgaria 2 Lysvulpen 100,946 2,042,920 20 3 Croatia 2 Lysvulpen 113,084 2,827,100 25 7 Cyprus No Czech Republic No Denmark No Estonia 2 Rabigen 18,650 373,000 20 5 Finland 1 Rabigen 9,000 180,000 20 3 France No Germany No Greece 1 Rabigen 54,584 1,317,983 24 10 Hungary 2 Lysvulpen 133,768 2,660,700 20 9 Ireland No Italy 1 Rabigen 2,385 49,312 21 0 Kosovo 1 Lysvulpen 10,000 250,000 25 1 Latvia 2 Lysvulpen 51,200 1,280,000 25 5 Lithuania 2 Lysvulpen 68,600 1,715,000 25 4 Luxembourg No FYROM 1 Lysvulpen 23,235 497,900 21 2 Montenegro 2 Lysvulpen 25,684 545,274 21 2 Netherlands No Norway No 8 Fuchsoral; 7,616,060 Poland 2 Lysvulpen 310,562 25 20 Lysvulpen Portugal No Romania 2 Lysvulpen 474,000 5,325,900 11 29 8 Fuchosral; 3,310,000 Serbia 2 Lysvulpen; Fuschoral 121,992 27 4 Lysvulpen Slovakia 2 Lysvulpen 24,413 607,600 25 3 Slovenia 2 Fuchsoral 38,000 874,000 23 3 Spain No Sweden No Switzerland No United Kingdom No Total 1,635,901 32,592,749 20 132 July 2016 Page 9/13

6.2 Sampling pressure in Monitoring The sampling pressure was calculated using the maximum number of animals collected in the frame of ORV monitoring (hunting bag origin from vaccinated areas) analysed for TTC (tetracycline) or serology. A ratio of animals analysed per 100 km 2 of the area vaccinated during the year was computed (sample size index: total number of animals tested in TTC or Serological analysis / (Maximum ORV area of the year) x100). Sampling pressure index was found highly variable depending on the country from 0.2 to 4.2 as compared to the previously recommended sample size for ORV monitoring of 4 individuals per 100 km 2 per year (WHO, 2005; EFSA, 2015). Nearly all the countries did not reach this target (Figure 7). Figure 7: Number of animals analysed in the frame of ORV monitoring (TTC or Serology) per 100 km 2 of vaccinated area in 2015. July 2016 Page 10/13

6.3 Percentage of Seroconversion in the target population Percentages of seroconversion were found highly variable and ranged from 26% to 73% (Figure 8). While all the South-Eastern European countries had a seroconversion level below 30% in 2012 and while half of the South-Eastern European countries had a seroconversion level below 30% in 2013, all except one presented a seroconversion level up to 30% in 2014 and 2015 suggesting a constant increase since few years. A variety of tests is used for the serological analysis within Europe: 14/18 laboratories (78%) used an ELISA kit (10 laboratories used BioPro and 4 used Biorad). In laboratory group not using ELISA tests, three laboratories (Croatia, Italy, Slovenia) used the FAVN test, and one laboratory (Slovakia) used a home made test. As in previous years, the variety of serological tests used within Europe and their sensitivity and specificity variations make the comparison of serological level among countries hazardous. Figure 8: Proportion of sero-conversion in the target population and type of test used in 2015. July 2016 Page 11/13

6.4 Percentage of tetracycline marking presence in target population The proportion of animals identified positive for the presence of tetracycline in teeth (bait uptake level) ranged from 46% to 98% (Figure 9). While it was noticed in 2012 that most of the south-western countries harboured a bait uptake level ranged between 30 and 60%, as for 2013 and 2014, in 2015 all of them evaluated their bait uptake level up to 60% (excepted for Montenegro with 46% of TTC positive samples). This trend could be explained by the fact that most of these countries started ORV in 2011 and that two consecutive years of vaccination are generally necessary to reach the overall target population. Nevertheless, 5 countries found their bait uptake level below the requested target of 70% of vaccination coverage required to achieve control and eventual elimination of rabies (WHO). Among the five countries, one (Finland) is vaccinating a buffer zone in the border only with the objective to build a rabies immune belt. Its low TTC level could be explained by an edge effect due to the small size of the vaccinated areas (9000 km 2 ). The areas being small, the perimeter-to-surface ratio is higher and the probability of sampling an unvaccinated animal in bordering areas is higher than for large ORV areas. Moreover, this country is vaccinating once per year. Albania presenting a bait uptake level of 61% is vaccinating since 2014 only. Figure 9: Proportion of samples positive for Tetracycline presence in jaws of the target population in 2015. July 2016 Page 12/13

ACKNOWLEDGMENTS We would like to thank all the participants in this review for kindly providing the data of the analysis performed in their laboratory and in regional laboratories of their network and Sylvie Tourdiat for her help in the elaboration of the online questionnaire and collection of the data. REFERENCES Scientific Panel on Animal Health and Welfare (AHAW) (2015). Update on oral vaccination of foxes and raccoon dogs against rabies. EFSA Journal. 70p. (http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4164.pdf) European Commission (2002). The oral vaccination of foxes against rabies. Report of the Scientific Committee on Animal Health and Animal Welfare. 55p. (http://ec.europa.eu/food/fs/sc/scah/out80_en.pdf) OIE (2013), Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 2.1.13. Rabies. Paris: 1-28 (http://www.oie.int/en/international-standard-setting/terrestrial-manual/access-online/) WHO (1996). Laboratory techniques in rabies. 4th edition ed, ed. F. Meslin, C. Kaplan, and H. Koprowski, Geneva. 476p. WHO (2005). WHO Expert Consultation on rabies. World Health Organization technical report series 931. Geneva. 121p. July 2016 Page 13/13